Clinical Trial Update: Sustained Unresponsiveness (SU) to Cashew Nut Protein Following Oral Allergen-Specific Immunotherapy [NA]

View source ↗

Summary

This clinical trial update describes an oral allergen-specific immunotherapy using cashew nut protein intended to induce sustained unresponsiveness in children …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cashew Nut Allergy
• Food Allergy

Drugs mentioned

• Cashew nut protein oral immunotherapy (cashew nut protein oral immunotherapy)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Food Allergy in Children | NA | Status: NOT_YET_RECRUITING